ISRG - Intuitive Surgical, Inc.
| Previous Close | 536.63 |
| Open | 533.25 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's Range | 525.37 - 544.85 |
| 52 Week Range | 430.24 - 589.32 |
| Volume | 1,420,868 |
| Avg. Volume | 815,315 |
| Market Cap | 61.051B |
| Beta (3Y Monthly) | 1.29 |
| PE Ratio (TTM) | 52.21 |
| EPS (TTM) | 10.13 |
| Earnings Date | Oct 16, 2019 - Oct 21, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 585.75 |
- Investor's Business Daily•8 hours ago
When To Sell Growth Stocks: How To Use A Carefully Drawn Trend Line
Learn the concept of drawing a good trend line along three lows in the stock's weekly chart. It can help you decide when to sell the best growth stocks.
- Motley Fool•20 hours ago
3 Stocks I'm Never Selling
Their competitive advantages and long-term growth prospects make these three stocks keepers.
- Investor's Business Daily•3 days ago
When To Buy Growth Stocks: Some Leaders Can Still Run After Forming Late Stage Bases
While Intuitive Surgical showed why late-stage bases are an excellent topping signal, it also proves how some great companies can eventually lead again.
- Investor's Business Daily•3 days ago
How One Key Metric Weighed On Intuitive Surgical's Attempted Breakout
Intuitive Surgical stock attempted a breakout Friday after the robotic surgery giant topped second-quarter earnings and sales estimates, though it saw a moderation in hernia procedures.
- InvestorPlace•3 days ago
Intuitive Surgical Earnings: ISRG Stock Down Despite Q2 Profit Beat
Intuitive Surgical (NASDAQ:ISRG) reported its latest quarterly earnings results today, which included a profit that increased year-over-year, yet the business' shares took a step back after an early rally.Source: Shutterstock The Sunnyvale, Calif.-based manufacturer and marketer of robotic items said that for its second quarter of the fiscal year -- which ended June 30 -- it amassed adjusted earnings of $3.25 per share. This amount was about 18% higher than they were during the same period a year ago.Intuitive Surgical also brought in a profit that surpassed the Wall Street consensus estimate of $2.85 per share, according to data compiled by Zacks Investment Research. Sales were higher as well, reaching about $1.1 billion, a 21% gain when stacked up against the same period in its previous fiscal year.InvestorPlace - Stock Market News, Stock Advice & Trading TipsWall Street saw the business raking in revenue of $1.03 billion in its average guidance. "Our teams remain focused on helping our customers improve outcomes and lower the total cost to treat per patient episode for their patient populations," Intuitive Surgical Gary Guthart said in a written statement.The business benefited from growth in U.S. general surgery, as well as worldwide urology procedures, which were good for a growth of 17% in the number of procedures that used the da Vinci robotic surgery system.ISRG stock is down about 0.9% Friday following the company's quarterly earnings results. More From InvestorPlace * 10 Tech Stocks That Are Still Worth Your Time (And Money) * 7 Stocks Top Investors Are Buying Now * 9 Retail Stocks Goldman Sachs Says Are Ready to Rip * 10 Stocks to Sell for an Economic Slowdown The post Intuitive Surgical Earnings: ISRG Stock Down Despite Q2 Profit Beat appeared first on InvestorPlace.
- Motley Fool•3 days ago
This Key Trend Continues at Intuitive Surgical
More hospitals are using this new method to get systems in-house.
- Benzinga•3 days ago
Intuitive Surgical's Q2 Performance Lauded By Bullish Analysts
Canaccord Genuity analyst Jason Mills maintained a Buy rating on Intuitive Surgical and lifted the price target from $575 to $610. Stifel analyst Rick Wise rates the shares a Buy, with a $570 price target. Morgan Stanley analyst David Lewis reiterated an Overweight rating and $620 price target.
- Zacks•3 days ago
Intuitive Surgical (ISRG) Q2 Earnings Beat, Guidance Narrowed
Intuitive Surgical (ISRG) expects 2019 procedure growth within 16-17%.
- Investor's Business Daily•3 days ago
Dow Jones Futures: After Fed-Led Stock Market Rally, Microsoft, Boeing, CrowdStrike Lead Big Movers
Futures signaled more stock market rally gains. Boeing sees an end to 737 Max woes, Microsoft rallied on earnings. CrowdStrike, Skechers surged past buy points.
- Thomson Reuters StreetEvents•3 days ago
Edited Transcript of ISRG earnings conference call or presentation 18-Jul-19 8:30pm GMT
Q2 2019 Intuitive Surgical Inc Earnings Call
Motley Fool•3 days agoIntuitive Surgical Inc (ISRG) Q2 2019 Earnings Call Transcript
ISRG earnings call for the period ending June 30, 2019.
- Investor's Business Daily•4 days ago
Robotic Surgery Giant Crushes Earnings Views; Is A Breakout Possible?
Intuitive Surgical earnings of $3.25 per share beat estimates as $1.1 billion in sales also topped. But Intuitive Surgical stock slipped late Thursday.
- GlobeNewswire•4 days ago
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 18, 2019 -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,.
- Investor's Business Daily•4 days ago
IBD's Investing Podcast: How To Make More Money In The Stock Market With Stock Charts
Investing with IBD is a weekly podcast focused on helping investors learn how to make more money in the stock market by using stock charts to find top stocks.
- Investing.com•4 days ago
Intuitive Surgical Earnings, Revenue Beat in Q2
Investing.com - Intuitive Surgical (NASDAQ:ISRG) reported second quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
- Investor's Business Daily•5 days ago
These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why
JNJ earnings report could be a boon for medical stocks Boston Scientific and Penumbra, an analyst said Wednesday. Boston has efforts in electrophysiology. Penumbra works in stroke treatment.
- Zacks•5 days ago
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks•6 days ago
The 5 Hottest Earnings Charts This Week
The 5 stocks have had the sizzle over the last 5 years. Will it continue this week?
- Zacks•6 days ago
Intuitive Surgical to Boost da Vinci Platform With Buyout
Intuitive Surgical's (ISRG) acquisition of Scholly Fiberoptic's robotic endoscope business to likely boost the acquirer's da Vinci Surgical system.
- GlobeNewswire•7 days ago
Intuitive Surgical acquires Schölly Fiberoptic’s robotic endoscope business
Intuitive (ISRG), the pioneer and a global leader in robotic-assisted, minimally invasive surgery and manufacturer of da Vinci surgical systems, today announced the acquisition of Schölly Fiberoptic’s robotic endoscope business. Intuitive is acquiring the robotic endoscope portion of Schölly Fiberoptic’s business.
- Simply Wall St.•7 days ago
Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Overpaying Its CEO?
In 2010 Gary Guthart was appointed CEO of Intuitive Surgical, Inc. (NASDAQ:ISRG). This analysis aims first to contrast...
- Motley Fool•7 days ago
3 Brand-Name Growth Stocks That Keep Getting Better With Age
Margins for these top growth stocks should significantly improve over time.
- Benzinga•9 days ago
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts . Pharma and biotech stocks took comfort in a ruling by a federal judge that went against President Donald ...
- Zacks•10 days ago
Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know
Intuitive Surgical (ISRG) closed the most recent trading day at $526.25, moving -1.82% from the previous trading session.
- InvestorPlace•10 days ago
4 Healthcare Stocks That Are Feeling Sick
While the broad U.S. equity market is pushing confidently to new all-time highs, healthcare stocks are lagging badly. The entire sector has come under pressure after President Donald Trump's effort to lower drug prices high a legal roadblock when a judge blocked a new requirement to list prices in commercials. The Trump Administration also reversed its plan to curb drug rebates for government healthcare plans.The pressure isn't slowing down, with the Health Care Select SPDR (NYSEARCA:XLV) cutting down out of a multi-week consolidation range to put an end to a three-month uptrend. This also marks a turnaround at resistance from the early December highs and sets up a decline back to the mid-April lows. * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond A number of big players in the sector are lagging badly. Here are four healthcare stocks to sell now:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Healthcare Stocks to Sell: Johnson & Johnson (JNJ)Shares of Johnson & Johnson (NYSE:JNJ) are dropping hard, down more than 4% on Friday as I write this and returning to lows not seen since early June. The move cuts below the stock's 200-day moving average and marks an inability to challenge the prior highs from back in December. The company continues to be dogged by legal risks related to baby powder asbestos claims.The company will next report results on July 16 before the bell. Analysts are looking for earnings of $2.42 per share on revenues of $20.4 billion. When the company last reported on April 16, earnings of $2.10 beat estimates by six cents on a 0.1% rise in revenues. Abbott Laboratories (ABT)Abbott Laboratories (NYSE:ABT) shares have fallen below their 20-day moving average for the first time since late May in what looks like the latest pullback within a secular uptrend that has been in play since 2016. Barclays analysts recently highlighted the company's impressive 7.1% organic revenue growth rate but noted very high investor expectations. Some profit taking should be expected. * 10 Stocks Driving the Market to All-Time Highs (And Why) The company will next report results on July 17 before the bell. Analysts are looking for earnings of 80 cents per share on revenues of $8 billion. When the company last reported on April 17, earnings of 63 cents per share beat estimates by a penny on a 2% rise in revenues. Intuitive Surgical (ISRG)Shares of Intuitive Surgical (NASDAQ:ISRG) are threatening to fall back below their 200-day moving average after struggling to reclaim that level after a nasty 22% decline from its mid-April high. This marks a continuation of a sideways range going back to the summer of 2018. The company is a maker of robotic surgical systems.The company will next report results on July 18 after the close. Analysts are looking for earnings of $2.87 per share on revenues of just over $1 billion. When the company last reported on April 18, earnings of $2.61 missed estimates by nine cents on a 14.9% rise in revenues. Illumnia (ILMN)Shares of Illumnia (NASDAQ:ILMN), which provides sequencing solutions for genetic analysis, is suffering a decline of more than 16% in mid-day trading after management guided second-quarter revenues below consensus estimates. Sales growth was impacted by lower than expected contributions from genomics initiatives. Shares were downgraded by analysts at Bank of America Merrill Lynch from buy to sell. Earlier this week, the stock hit an all-time high. * 7 Retail Stocks to Buy for the Second Half of 2019 ISRG stock will next report results on July 29 after the close. Analysts are looking for earnings of $1.42 per share on revenues of $885.6 million. When the company last reported on April 25, earnings of $2.56 beat estimates by 30 cents per share on an 8.2% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy for Less Than Book * 7 Marijuana Stocks With Critical Levels to Watch * The 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The post 4 Healthcare Stocks That Are Feeling Sick  appeared first on InvestorPlace.
